Increased innate immune responses in adolescents with obesity and its relation to subclinical cardiovascular measures: An exploratory study.

Disease Health sciences Immunology Pathophysiology Risk factor

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 13 11 2023
revised: 16 02 2024
accepted: 15 04 2024
medline: 14 5 2024
pubmed: 14 5 2024
entrez: 14 5 2024
Statut: epublish

Résumé

Cardiometabolic risk accrues across the life course and childhood and adolescence are key periods for effective prevention. Obesity is associated with inflammation in adults, but pediatric data are scarce. In a cross-sectional and longitudinal study, we investigated immune cell composition and activation in 31 adolescents with obesity (41.9% male, BMIz>2.5, 14.4 years) and 22 controls with healthy weight (45.1% male, -1.5<BMIz<1.5, 14 years). In those with obesity, we assessed the impact of weight change and correlations between immune profiles and subclinical cardiovascular phenotypes at a 5-year follow-up. Compared to controls, those with obesity had increased monocyte activation and cytokine production upon stimulation. Monocyte transcriptomics demonstrated upregulated inflammatory pathways and downregulated antiviral responses. Weight change was not associated with changes in inflammation. Baseline inflammation correlated with cardiovascular measures at follow-up. Children with obesity have increased inflammation, which associates with worse subsequent subclinical cardiovascular measures. Adjunctive anti-inflammatory interventions may be needed to reverse adverse subclinical cardiovascular phenotypes.

Identifiants

pubmed: 38741712
doi: 10.1016/j.isci.2024.109762
pii: S2589-0042(24)00984-2
pmc: PMC11089376
doi:

Types de publication

Journal Article

Langues

eng

Pagination

109762

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

M.G.N. is scientific founder of TTxD and Lemba Therapeutics.

Auteurs

Siroon Bekkering (S)

Department of Internal Medicine, Radboud University Medical Centre, Nijmegen 6525 GA, the Netherlands.
Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.

Christoph Saner (C)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, University Children`s Hospital Bern, Inselspital, Bern 3010, Switzerland.
Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland.

Boris Novakovic (B)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.

Toby Mansell (T)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.

Danielle K Longmore (DK)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Department of Endocrinology, The Royal Children`s Hospital, Parkville, VIC 3052, Australia.

Zoe McCallum (Z)

Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.
Department of Neurodevelopment and Disability, Royal Children's Hospital, Parkville, VIC 3052, Australia.

Anne-Louise Ponsonby (AL)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3052, Australia.

Markus Juonala (M)

Department of Medicine, University of Turku, 20500 Turku, Finland.
Division of Medicine, Turku University Hospital, 20500 Turku, Finland.

Mihai G Netea (MG)

Department of Internal Medicine, Radboud University Medical Centre, Nijmegen 6525 GA, the Netherlands.
Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.

Matthew A Sabin (MA)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Department of Endocrinology, The Royal Children`s Hospital, Parkville, VIC 3052, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.

Richard Saffery (R)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.

Niels P Riksen (NP)

Department of Internal Medicine, Radboud University Medical Centre, Nijmegen 6525 GA, the Netherlands.

David P Burgner (DP)

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, VIC 3052, Australia.
Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia.
Department of Pediatrics, Monash University, Clayton, VIC 3168, Australia.

Classifications MeSH